• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[生物衰老与细胞凋亡——心血管疾病的机制?]

[Biological aging and apoptosis--mechanism in cardiovascular disease?].

作者信息

Nilsson P

机构信息

Klinisk forskningsenhet, Universitetssjukhuset, Malmö.

出版信息

Nord Med. 1998 Mar;113(3):82-4.

PMID:9528285
Abstract

Smoking, lipid disorders, hypertension and diabetes are well known risk factors for cardiovascular disease. Many individuals are characterised by a genetically determined predisposition and moreover, psychosocial factors and an inappropriate life style may exert adverse effects on biological variables. Evidence exists which suggests that in such cases various ageing processes may be accelerated. Studies of apoptosis regulation can yield improved understanding of such phenomena as atherosclerotic plaque rupture and such structural cardiovascular changes as left ventricular hypertrophy. A possible clinical result of such events may be manifest myocardial infarction, followed by heart failure and a predisposition to arrhythmia. The recent identification of apopain, a proteolytic enzyme associated with apoptosis, may eventually enable drugs to be developed for the regulation of apoptosis.

摘要

吸烟、脂代谢紊乱、高血压和糖尿病是众所周知的心血管疾病风险因素。许多人具有遗传决定的易感性,此外,社会心理因素和不恰当的生活方式可能会对生物变量产生不利影响。有证据表明,在这些情况下,各种衰老过程可能会加速。对细胞凋亡调节的研究可以更好地理解动脉粥样硬化斑块破裂等现象以及左心室肥厚等心血管结构变化。这些事件可能导致的临床后果可能是明显的心肌梗死,继而出现心力衰竭和心律失常倾向。最近发现的凋亡蛋白酶,一种与细胞凋亡相关的蛋白水解酶,最终可能使开发调节细胞凋亡的药物成为可能。

相似文献

1
[Biological aging and apoptosis--mechanism in cardiovascular disease?].[生物衰老与细胞凋亡——心血管疾病的机制?]
Nord Med. 1998 Mar;113(3):82-4.
2
The aging hypertensive heart: a brief update.衰老性高血压心脏:简要更新
Nat Clin Pract Cardiovasc Med. 2008 Feb;5(2):104-10. doi: 10.1038/ncpcardio1091.
3
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.心血管危险因素与心肌缺血/再灌注损伤、预处理及后处理之间的相互作用。
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
4
The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.勃起功能障碍与心血管疾病的关系。第一部分:病理生理学与机制。
Rev Cardiovasc Med. 2007 Fall;8(4):214-9.
5
Mechanical factors in arterial aging: a clinical perspective.动脉衰老中的机械因素:临床视角
J Am Coll Cardiol. 2007 Jul 3;50(1):1-13. doi: 10.1016/j.jacc.2006.12.050. Epub 2007 Jun 18.
6
[Sleep apnea syndromes and cardiovascular disease].[睡眠呼吸暂停综合征与心血管疾病]
Bull Acad Natl Med. 2005 Mar;189(3):445-59; discussion 460-4.
7
[Heart failure in elderly patients].老年患者的心力衰竭
Praxis (Bern 1994). 1995 Oct 31;84(44):1272-6.
8
Circulating endothelial progenitor cells in cardiovascular disorders.心血管疾病中的循环内皮祖细胞
Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1115-21. doi: 10.1586/14779072.6.8.1115.
9
Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.盐皮质激素与心血管疾病。实验研究和临床研究的知识现状。
Ital Heart J. 2000 Sep;1(9):595-604.
10
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.高血压和左心室肥厚患者的体型与心血管事件风险: LIFE(氯沙坦干预降低高血压终点事件)研究
Circulation. 2005 Apr 19;111(15):1924-31. doi: 10.1161/01.CIR.0000161799.91577.0A.